Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib + AI in Real-world First-line Metastatic Breast Cancer
NCT04858997Phase 2Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Apr 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in breast cancer, sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04858997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04858997.